PRESS RELEASE
News
-
-
REGULATED PRESS RELEASE
Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, marking a significant milestone in developing therapies for muscle loss in aging individuals -
PRESS RELEASE
Exail strengthens its position in the surface drone sector with the first sale of a new long-range DriX drone model
Exail Technologies announces the sale of the DriX H-9, expanding its autonomous surface drone solutions for civil and defense markets. The H-9 offers enhanced capabilities for maritime missions -
-
-
-
PRESS RELEASE
Ad hoc announcement pursuant to Art. 53 LR: Jungfraubahn Holding AG - The Jungfrau Railway Group achieves record profit in the first half of the year
Jungfraubahn Holding AG reports record profit in the first half of 2025, driven by increased transport income. New CEO and sustainability efforts highlighted -
PRESS RELEASE
Helvetica Swiss Commercial Fund impresses in the first half of 2025 with strong net income, performance above the benchmark and successful fund merger
Helvetica Swiss Commercial Fund achieves strong net income and performance above benchmark in first half of 2025 with a successful fund merger. Details in HSC Fund's 2025 Half-Year Report -
PRESS RELEASE
Helvetica Swiss Living Fund impresses in the first half of 2025 with significantly higher total profit, increased net income per unit and strong return on investment
Helvetica Swiss Living Fund reports strong financial performance in the first half of 2025, with increased net income per unit and 2.94% return on investment -
